HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Omalizumab induced remission of idiopathic anaphylaxis in a patient suffering from indolent systemic mastocytosis.

AuthorsLine Kibsgaard, Tina Skjold, Mette Deleuran, Christian Vestergaard
JournalActa dermato-venereologica (Acta Derm Venereol) Vol. 94 Issue 3 Pg. 363-4 (May 2014) ISSN: 1651-2057 [Electronic] Sweden
PMID24162824 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Allergic Agents
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal, Humanized
  • Omalizumab
Topics
  • Adult
  • Anaphylaxis (diagnosis, drug therapy, immunology)
  • Anti-Allergic Agents (therapeutic use)
  • Antibodies, Anti-Idiotypic (therapeutic use)
  • Antibodies, Monoclonal, Humanized (therapeutic use)
  • Humans
  • Male
  • Mast Cells (drug effects, immunology)
  • Mastocytosis, Systemic (diagnosis, drug therapy, immunology)
  • Omalizumab
  • Recurrence
  • Remission Induction
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: